Allegheny Health Network

Pittsburgh, Pennsylvania 15224

31 studies enrolling now · 87 studies all time

What they study most

AAA, AAA - Abdominal Aortic Aneurysm, Acute Heart Failure, Acute Myeloid Leukemia (AML), Acute T Cell Leukemia Lymphoma, Adenocarcinoma of the Prostate, Alzheimer Disease, Anal Fistula, Anal Squamous Cell Carcinoma, Anemia, Aneurysmal Subarachnoid Hemorrhage (aSAH), Arrhythmia

Studies at this site

• Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care — Recruiting now
• CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial — Recruiting now
• A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy — Recruiting now
• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) — Recruiting now
• Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors — Recruiting now
• A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer — Recruiting now
• This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations. — Recruiting now
• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V — Recruiting now
• AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy — Recruiting now
• Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) — Recruiting now
• HeartBeam ECG Registry — Recruiting now
• RA-PRO PRAGMATIC TRIAL — Recruiting now
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer — Recruiting now
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias — Recruiting now
• Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body — Recruiting now
• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. — Recruiting now
• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG — Recruiting now
• Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar — Recruiting now
• MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach — Recruiting now
• Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts — Recruiting now
• The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR — Recruiting now
• A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) — Recruiting now
• Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma — Recruiting now
• The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study — Recruiting now
• Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch — Recruiting now
• A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. — Recruiting now
• ACDF Using Structural Allograft vs. Tritanium C — Recruiting now
• A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas — Recruiting now
• MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles — Recruiting now
• Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel — Recruiting now
• Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus — Recruiting now
• JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization — Recruiting now
• Study of INCB123667 in Subjects With Advanced Solid Tumors — Running, not enrolling
• Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection — Completed
• An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions — Running, not enrolling
• A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA — Completed
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• Registry of Asthma Patients Initiating DUPIXENT® — Completed
• Utility of Random Biopsies in Patients With Inflammatory Bowel Disease — Enrolling by invitation
• Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC — Completed
• Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL — Running, not enrolling
• 9-ING-41 in Patients With Advanced Cancers — Running, not enrolling
• CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung — Running, not enrolling
• Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer — Running, not enrolling
• A Registry for Patients With Multifocal Ground Glass Opacities (GGOs) — Running, not enrolling
• Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Running, not enrolling
• Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection — Completed
• Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) — Stopped early